The Treatment Action Group’s 2014 Pipeline Report released in conjunction with the 20th International AIDS Conference last week devotes three sections to the outlook for better and more accessible treatment for hepatitis C, examining the promise of new direct acting antiviral treatments, starting with sofosbuvir (marketed by Gilead pharmaceutical company as Sovaldi) being eclipsed by […]
HIV
With an ambitious, but yet to be funded federal plan to end the American HIV epidemic within the next 10 years in front of Congress, about […]
Tuberculosis
HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an […]
Research & Development
While the committee examining the Ebola epidemic in the Democratic Republic of Congo emerged today from its 5th meeting with the conclusion that transmissions of the […]
Policy
DRC, Liberia, Madagascar, Somalia and Ukraine account for nearly half of global measles cases Measles incidence increased in five regions around the world between 2016 and […]